Clinical Case Study Compendium:

PDF case reports 1 & 2

The impact of gilteritinib in daily practice as salvage treatment and as bridging therapy. Real-World Experiences by Dr. A. de Voeght...

Accessible only to healthcare professionals authorized to prescribe

Part 2: Clinical Case Study Compendium:

PDF case reports 3 & 4

The impact of gilteritinib in daily practice after intensive chemotherapy and following an ...

The Role of Gilteritinib in the Treatment of Relapsed or Refractory FLT3-Mutated AML¹

Video

Video of case report 5:

In this interview with Prof. Dr. M. Beckers (UZ Leuven, Belgium), she discusses her experiences with gilteritinib as salvage and MRD²-directed therapy in a post-transplant setting.

Intended for: practitioners hematology
Why: up-to-date knowledge TKI³ related target therapy
When: Watch now
Duration: 4 minutes

1: Acute Myeloid Leukemia; 2: Hematopoietic Stem Cell Transplantation

MAT-BE-XOS-2026-00005 MRT 2026

Log in and watch

AML: Acute Myeloid Leukemia

Dutch
English
French

Clinical Case Study Compendium:

PDF case reports 1 & 2

Part 2: Clinical Case Study Compendium:

PDF case reports 3 & 4

The Role of Gilteritinib in the Treatment of Relapsed or Refractory FLT3-Mutated AML¹

Video

You are now leaving aml-hematology.be.

Item was added to cart

Toestemming

Toestemming

Account aanmaken

Instemming

Toestemming

Toestemming

Verification code

Emailadres bevestigen en account aanmaken

Emailadres bevestigen en account aanmaken

Access with your RIZIV/INAMI or BIG Number

RIZIV/INAMI or BIG number *

Login

U gaat naar een externe website

U gaat naar een andere website van Astellas

Please confirm your involvement.